Cart
sales@molnova.com
Kudinoside D
CAS No. 173792-61-5
Kudinoside D( —— )
Catalog No. M23783 CAS No. 173792-61-5
Kudinoside D exerts anti-adipogenic effects through modulation of adipogenic transcription factors via AMPK signaling pathway.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 341 | In Stock |
|
| 5MG | 283 | In Stock |
|
| 10MG | 395 | In Stock |
|
| 25MG | 610 | In Stock |
|
| 50MG | 809 | In Stock |
|
| 100MG | 1088 | In Stock |
|
| 200MG | 1469 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameKudinoside D
-
NoteResearch use only, not for human use.
-
Brief DescriptionKudinoside D exerts anti-adipogenic effects through modulation of adipogenic transcription factors via AMPK signaling pathway.
-
DescriptionKudinoside D exerts anti-adipogenic effects through modulation of adipogenic transcription factors via AMPK signaling pathway.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetAMPK
-
RecptorAMPK|LDL|PPAR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number173792-61-5
-
Formula Weight909.07
-
Molecular FormulaC47H72O17
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (110.00 mM)
-
SMILESC[C@@H]([C@@H]([C@H]([C@H]1O)O)O)O[C@H]1O[C@H]([C@H]1O[C@@H]([C@@H]([C@H]2O)O)O[C@H](CO)[C@H]2O)[C@H](O[C@@H](CC2)C(C)(C)[C@H](CC[C@@]3(C)[C@]4(C)CC5)[C@@]2(C)[C@H]3C=CC4=C([C@@](C)(C(C)(CC2)O3)O)[C@@]25C3=O)OC[C@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
PF-06885249
PF-06885249 (PF06885249) is a potent, direct AMPK activator with EC50 of 7.0 and 27 nM for α1β1γ1 and α2β1γ1, respectively.
-
MT 63-78
MT 63-78 is a specific and effective direct AMPK activator (EC50: 25 μM). MT 63-78 blocks prostate cancer growth by inhibiting the lipogenesis and mTORC1 pathways.
-
Gomisin J
Gomisin J is a natural product and have vasodilatory activity.?Gomisin J suppresses lipid accumulation by regulating the expression of lipogenic and lipolytic enzymes and inflammatory molecules through activation of AMPK, LKB1 and Ca2+/calmodulin-dependent protein kinase II and inhibition of fetuin-A in HepG2 cells.
